Aprinoia Revenue and Competitors
Estimated Revenue & Valuation
- Aprinoia's estimated annual revenue is currently $5.9M per year.
- Aprinoia's estimated revenue per employee is $155,000
Employee Data
- Aprinoia has 38 Employees.
- Aprinoia grew their employee count by -7% last year.
Aprinoia's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Group General Counsel and interim Chief Operations Officer | Reveal Email/Phone |
3 | VP, Global Head Program Management | Reveal Email/Phone |
4 | SVP & Global Head Regulatory Affairs | Reveal Email/Phone |
5 | Sr. Director and Head Clinical Operations | Reveal Email/Phone |
6 | Director, Human Resources | Reveal Email/Phone |
7 | Executive Assistant to Chief Medical Officer & Chief Financial Officer | Reveal Email/Phone |
8 | Chief Financial Officer | Reveal Email/Phone |
9 | Chief Medical Officer | Reveal Email/Phone |
10 | Senior Payroll and HR Specialist | Reveal Email/Phone |
Aprinoia Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Aprinoia?
Aprinoia Therapeutics is dedicated to establish a drug discovery and early development company that is based on innovation and scientific rigor and integrity. Our goal is to create novel products to meet critical patient needs, including: 1) Novel imaging-based diagnostic tools to improve the detection of occurrence, progression, and regression of neurological diseases; and 2) Novel therapies to improve the treatment of human neurological conditions.
keywords:N/A
N/A
Total Funding
38
Number of Employees
$5.9M
Revenue (est)
-7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Aprinoia News
2022-04-13 - APRINOIA Therapeutics received FDA clearance to initiate ...
APRINOIA Therapeutics received FDA clearance to initiate APNmAb005 Phase 1 clinical trial. Published: Apr 11, 2022. BOSTON, April 11, 2022 /PRNewswire/...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.5M | 38 | 0% | N/A |
#2 | $7.8M | 38 | 6% | $200M |
#3 | $7.4M | 38 | 0% | N/A |
#4 | $7.6M | 38 | -14% | N/A |
#5 | $6.2M | 38 | -39% | N/A |